Back to Market Feed

SKYRIZI 150 MG/ML PEN

risankizumab-rzaa
$22807.7000per ML

Strength

150 mg/mL

Manufacturer

AbbVie Inc.

NDC

00074210001

Classification

Brand

Dosage Form

INJECTION

Route

SUBCUTANEOUS

Last Updated

1/2/2026

Active Ingredients

RISANKIZUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA761105

On Market Since

4/26/2021

Pharmacological Classes

Interleukin-23 Antagonist
Interleukin-23 Antagonists

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+6.5%

1Y

+6.0%

3Y

+19.7%

5Y

N/A

All

+28.9%

Generic Alternatives

1 alternative • Same active ingredient

SKYRIZI 150 MG/ML SYRINGE
Brand
00074105001•AbbVie Inc.
$22942.3716
+1% more

Related Drugs

Same classification

TREMFYA 200 MG/2 ML PEN
Brand
57894065102•Janssen Biotech, Inc.
$7349.6703
per ML
TREMFYA 100 MG/ML ONE-PRESS
Brand
57894064011•Janssen Biotech, Inc.
$14766.3280
per ML
TREMFYA 100 MG/ML SYRINGE
Brand
57894064001•Janssen Biotech, Inc.
$14769.7353
per ML
STELARA 90 MG/ML SYRINGE
Brand
57894006103•Janssen Biotech, Inc.
$29794.5447
per ML
STELARA 45 MG/0.5 ML SYRINGE
Brand
57894006003•Janssen Biotech, Inc.
$29841.6480
per ML